The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Leukemia

• Publication date

  2011-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/leu.2011.122PMID 21637285
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The prolyl‐hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia

  2010cited by this paper
• Hypoxia and activated VEGF/receptor pathway in multiple myeloma.

  2010cited by this paper
• Hypoxia-inducible factors and the response to hypoxic stress.

  2010cited by this paper
• Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells

  2010cited by this paper
• Low bone marrow oxygen tension and hypoxia-inducible factor-1α overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138+ cells

  2010cited by this paper
• Multiple receptor tyrosine kinases regulate HIF-1α and HIF-2α in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors

  2010cited by this paper
• Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug.

  2010cited by this paper
• Targeting angiogenesis via a c-Myc/hypoxia-inducible factor-1alpha-dependent pathway in multiple myeloma.

  2009cited by this paper
• Inhibition of hypoxia-inducible factor-1 function enhances the sensitivity of multiple myeloma cells to melphalan

  2009cited by this paper
• Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells

  2009cited by this paper
• The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions.

  2009cited by this paper
• Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells.

  2009cited by this paper
• Reply to C.D. Atkins

  2009cited by this paper
• Final results of a phase I study of TH-302, a hypoxia-activated cytotoxic prodrug (HAP).

  2009cited by this paper
• Prevention of hypoxia by myoglobin expression in human tumor cells promotes differentiation and inhibits metastasis.

  2009cited by this paper
• Oncogenic KRAS and BRAF differentially regulate hypoxia-inducible factor-1alpha and -2alpha in colon cancer.

  2009cited by this paper
• Hypoxia-Inducible Factor-1 in Multiple Myeloma Progression.

  2009cited by this paper
• Hypoxia inducible factor‐alpha activation in lymphoma and relationship to the thioredoxin family

  2008cited by this paper
• Dysregulated angiogenesis in B-chronic lymphocytic leukemia: Morphologic, immunohistochemical, and flow cytometric evidence

  2008cited by this paper
• Bortezomib inhibits tumor adaptation to hypoxia by stimulating the FIH-mediated repression of hypoxia-inducible factor-1.

  2008cited by this paper
• Abnormal Sympathoadrenal Development and Systemic Hypotension in PHD3−/− Mice

  2008cited by this paper
• Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia

  2008cited by this paper
• A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growth

  2008cited by this paper
• Phosphorylated VEGFR2/KDR receptors are widely expressed in B‐cell non‐Hodgkin's lymphomas and correlate with hypoxia inducible factor activation

  2008cited by this paper
• Hypoxia-Associated Factor, a Novel E3-Ubiquitin Ligase, Binds and Ubiquitinates Hypoxia-Inducible Factor 1α, Leading to Its Oxygen-Independent Degradation

  2008cited by this paper
• Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugs.

  2008cited by this paper
• The impact of O2 availability on human cancer

  2008cited by this paper
• The interplay between MYC and HIF in cancer

  2008cited by this paper
• Combination Strategy Targeting the Hypoxia Inducible Factor-1α with Mammalian Target of Rapamycin and Histone Deacetylase Inhibitors

  2008cited by this paper
• Biology of hypoxia-inducible factor-2α in development and disease

  2008cited by this paper
• Improved survival in multiple myeloma and the impact of novel therapies.

  2008cited by this paper
• PX‐478, an inhibitor of hypoxia‐inducible factor‐1α, enhances radiosensitivity of prostate carcinoma cells

  2008cited by this paper
• YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.

  2007cited by this paper
• The anticancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions

  2007cited by this paper
• YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-κB signaling to HIF-1α accumulation during hypoxia

  2007cited by this paper
• Fluctuating and Diffusion-Limited Hypoxia in Hypoxia-Induced Metastasis

  2007cited by this paper
• Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia

  2007cited by this paper
• Hypoxia Inducible Factor-2α in Cancer

  2007cited by this paper
• The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesis.

  2007cited by this paper
• Effects of YC-1 on Hypoxia-Inducible Factor 1-Driven Transcription Activity, Cell Proliferative Vitality, and Apoptosis in Hypoxic Human Pancreatic Cancer Cells

  2007cited by this paper
• Overexpression of hypoxia-inducible factor-1alpha in human osteosarcoma: correlation with clinicopathological parameters and survival outcome.

  2007cited by this paper
• Hematopoietic Progenitor Cell Mobilization Results in Hypoxia with Increased Hypoxia‐Inducible Transcription Factor‐1α and Vascular Endothelial Growth Factor A in Bone Marrow

  2007cited by this paper
• Mammalian Tumor Suppressor Int6 Specifically Targets Hypoxia Inducible Factor 2α for Degradation by Hypoxia- and pVHL-independent Regulation*

  2007cited by this paper
• The N-Terminal Transactivation Domain Confers Target Gene Specificity of Hypoxia-inducible Factors HIF-1α and HIF-2α

  2007cited by this paper
• Prediction of Avascular Necrosis of the Femoral Head by Measuring Intramedullary Oxygen Tension After Femoral Neck Fracture

  2007cited by this paper
• HIF-dependent antitumorigenic effect of antioxidants in vivo.

  2007cited by this paper
• The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha.

  2007cited by this paper
• Celecoxib could reverse the hypoxia-induced Angiopoietin-2 upregulation in gastric cancer.

  2006cited by this paper
• Nitric oxide is a factor in the stabilization of hypoxia-inducible factor-1alpha in cancer: role of free radical formation.

  2006cited by this paper
• Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1α activity and vascular endothelial growth factor expression in small cell lung cancer cells

  2006cited by this paper
• Differential regulation of the transcriptional activities of hypoxia-inducible factor 1 alpha (HIF-1alpha) and HIF-2alpha in stem cells.

  2006cited by this paper
• Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype.

  2006cited by this paper
• Bone-marrow haematopoietic-stem-cell niches

  2006cited by this paper
• Proteasomal Inhibition Attenuates Transcriptional Activity of Hypoxia-Inducible Factor 1 (HIF-1) via Specific Effect on the HIF-1α C-Terminal Activation Domain

  2006cited by this paper
• Effects of Histone Deacetylase Inhibitors on HIF-1

  2006cited by this paper
• Cell-specific regulation of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha stabilization and transactivation in a graded oxygen environment.

  2006cited by this paper
• The Transcriptional Activator Hypoxia Inducible Factor 2 (HIF-2/EPAS-1) Regulates the Oxygen-Dependent Expression of Erythropoietin in Cortical Astrocytes

  2006cited by this paper
• EGFR tyrosine kinase inhibitors decrease VEGF expression by both hypoxia-inducible factor (HIF)-1-independent and HIF-1-dependent mechanisms.

  2006cited by this paper
• Differential Regulation of the Transcriptional Activities of Hypoxia-Inducible Factor 1 Alpha (HIF-1α) and HIF-2α in Stem Cells

  2006cited by this paper
• Cell-specific Regulation of Hypoxia-inducible Factor (HIF)-1α and HIF-2α Stabilization and Transactivation in a Graded Oxygen Environment*

  2006cited by this paper
• Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human Cancers

  2006cited by this paper
• Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators.

  2005cited by this paper
• A Rationally Designed Small Molecule That Inhibits the HIF-1α–ARNT Heterodimer from Binding to DNA in Vivo

  2005cited by this paper
• The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products.

  2005cited by this paper
• The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression

  2005cited by this paper
• Both microtubule-stabilizing and microtubule-destabilizing drugs inhibit hypoxia-inducible factor-1alpha accumulation and activity by disrupting microtubule function.

  2005cited by this paper
• Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progression.

  2005cited by this paper
• Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell Carcinoma

  2005cited by this paper
• Novel aspects of osteoclast activation and osteoblast inhibition in myeloma bone disease.

  2005cited by this paper
• Expression of Hypoxia-Inducible Factor-1α Protein Predicts Survival in Patients with Transitional Cell Carcinoma of the Upper Urinary Tract

  2005cited by this paper
• Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1.

  2005cited by this paper
• Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract.

  2005cited by this paper
• Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1α

  2004cited by this paper
• Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha.

  2004cited by this paper
• Glycobiology and Cancer: Meeting Summary and Future Directions

  2004cited by this paper
• Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF

  2004cited by this paper
• NS398 reduces hypoxia‐inducible factor (HIF)‐1α and HIF‐1 activity: Multiple‐level effects involving cyclooxygenase‐2 dependent and independent mechanisms

  2004cited by this paper
• Acute Hypoxia Enhances Spontaneous Lymph Node Metastasis in an Orthotopic Murine Model of Human Cervical Carcinoma

  2004cited by this paper
• Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF

  2004cited by this paper
• 2-Methoxyestradiol Inhibits Hypoxia-Inducible Factor 1α, Tumor Growth, and Angiogenesis and Augments Paclitaxel Efficacy in Head and Neck Squamous Cell Carcinoma

  2004cited by this paper
• Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer.

  2004cited by this paper
• Hydroxylation of HIF-1: oxygen sensing at the molecular level.

  2004cited by this paper
• mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

  2004cited by this paper
• Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

  2004cited by this paper
• Exploiting tumour hypoxia in cancer treatment

  2004cited by this paper
• Yeast as a model system for anticancer drug discovery

  2004cited by this paper
• Hypoxic gene expression and metastasis

  2004cited by this paper
• The hypoxic tumour microenvironment and metastatic progression

  2004cited by this paper
• Predominant role of hypoxia-inducible transcription factor (Hif)-1alpha versus Hif-2alpha in regulation of the transcriptional response to hypoxia.

  2003cited by this paper
• Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells.

  2003cited by this paper
• Angiogenesis in ischemic and neoplastic disorders.

  2003cited by this paper
• Prognostic significance of HIF-1 alpha overexpression in human pancreatic cancer.

  2003cited by this paper
• Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma

  2003cited by this paper
• Expansion of human SCID-repopulating cells under hypoxic conditions.

  2003cited by this paper
• Multiple Splice Variants of the Human HIF-3α Locus Are Targets of the von Hippel-Lindau E3 Ubiquitin Ligase Complex*

  2003cited by this paper
• HIF prolyl‐hydroxylase 2 is the key oxygen sensor setting low steady‐state levels of HIF‐1α in normoxia

  2003cited by this paper
• YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.

  2003cited by this paper
• Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation.

  2003cited by this paper
• Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation

  2003cited by this paper
• Ibuprofen-mediated Reduction of Hypoxia-inducible Factors HIF-1α and HIF-2α in Prostate Cancer Cells

  2003cited by this paper

• MMSA-1 is regulated by Wnt/TCF4 and involved in multiple myeloma progression and invasion via RAS/RAF signaling pathway

  2026cites this paper
• Network analysis of master regulators associated with invasive phenotypes in multiple myeloma

  2025cites this paper
• Prognostic and therapeutic implications of disulfidptosis-related genes in multiple myeloma

  2025cites this paper
• A comprehensive review of the PTEN/PI3K/Akt axis in multiple myeloma: From molecular interactions to potential therapeutic targets.

  2024cites this paper
• Advancements in microenvironment-based therapies: transforming the landscape of multiple myeloma treatment

  2024cites this paper
• The implication of serum HLA-G in angiogenesis of multiple myeloma

  2024cites this paper
• The association of Hypoxia-Inducible Factor-2α (HIF-2α) overexpression score with Germinal Center B-Cell Like (GCB) and Non-Germinal Center B-Cell Like (Non-GCB) subtypes of Diffuse Large B-cell Lymphoma (DLBCL)

  2023cites this paper
• Acidification of intracellular pH in MM tumor cells overcomes resistance to hypoxia-mediated apoptosis in vitro and in vivo

  2023cites this paper
• Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma

  2023cites this paper
• The effect of hypoxia on GLI expression and their downstream effect in Waldenström Macroglobulinemia

  2023cites this paper
• Hypoxic bone marrow stromal cells secrete miR-140-5p and miR-28-3p target SPRED1 to confer drug resistance in multiple myeloma.

  2023cites this paper
• Challenges for CAR-T cell therapy in multiple myeloma: overcoming the tumor microenvironment

  2023cites this paper
• Atypical induction of HIF-1α expression by pericellular Notch1 signaling suffices for the malignancy of glioblastoma multiforme cells

  2022cites this paper
• An emerging prognosis prediction model for multiple myeloma: Hypoxia-immune related microenvironmental gene signature

  2022cites this paper
• Epigenetic Crosstalk between Malignant Plasma Cells and the Tumour Microenvironment in Multiple Myeloma

  2022cites this paper
• Hypoxia induces chemoresistance to proteasome inhibitors through orchestrating deSUMOylation and ubiquitination of SRC-3 in multiple myeloma

  2022cites this paper
• Active Components of Traditional Chinese Medicinal Material for Multiple Myeloma: Current Evidence and Future Directions

  2022cites this paper
• Targeting Reactive Oxygen Species Metabolism to Induce Myeloma Cell Death

  2021cites this paper
• Hipoksi ve Kanser

  2021cites this paper
• Multiple Myeloma Cell-Derived Exosomes: Implications on Tumorigenesis, Diagnosis, Prognosis and Therapeutic Strategies

  2021cites this paper
• Modulating tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors: A TAM-pting approach.

  2021cites this paper
• MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease

  2021cites this paper
• The impact of hypoxia on B cells in COVID-19

  2021cites this paper
• Der Eisenstoffwechsel und seine Bedeutung für das Höhentraining

  2021cites this paper
• Crosstalk between endoplasmic reticulum stress and oxidative stress: a dynamic duo in multiple myeloma

  2021cites this paper
• Treatment Strategies Considering Micro-Environment and Clonal Evolution in Multiple Myeloma

  2021cites this paper
• Targeting the Endothelin-1 Receptors Curtails Tumor Growth and Angiogenesis in Multiple Myeloma

  2021cites this paper
• Hypoxia‐inducible hexokinase‐2 enhances anti‐apoptotic function via activating autophagy in multiple myeloma

  2020cites this paper
• Oxidative Stress Induces a VEGF Autocrine Loop in the Retina: Relevance for Diabetic Retinopathy

  2020cites this paper
• Enhancing the chemotherapy effect of Apatinib on gastric cancer by co-treating with salidroside to reprogram the tumor hypoxia micro-environment and induce cell apoptosis

  2020cites this paper
• Tumour Dissemination in Multiple Myeloma Disease Progression and Relapse: A Potential Therapeutic Target in High-Risk Myeloma

  2020cites this paper
• Understanding Gamma Delta T Cell Multifunctionality - Towards Immunotherapeutic Applications

  2020cites this paper
• A SUMOylation-dependent HIF-1α/CLDN6 negative feedback mitigates hypoxia-induced breast cancer metastasis

  2020cites this paper
• Galectins as regulators of cell survival in the leukemia niche.

  2019cites this paper
• UvA-DARE ( Digital Academic Repository ) Wnt signaling in the pathogenesis of multiple myeloma

  2019cites this paper
• The Yin and Yang of cancer genes.

  2019cites this paper
• PYK2/FAK inhibitors reverse hypoxia-induced drug resistance in multiple myeloma

  2019cites this paper
• Metabolic, Anti-apoptotic and Immune Evasion Strategies of Primary Human Myeloma Cells Indicate Adaptations to Hypoxia*

  2019cites this paper
• IMiDs mediate their anti-myeloma activity via destabilization of the CD147/MCT1 complex

  2018cites this paper
• Vγ9Vδ2 T Cells in the Bone Marrow of Myeloma Patients: A Paradigm of Microenvironment-Induced Immune Suppression

  2018cites this paper
• Extracellular vesicle-mediated cell–cell communication in haematological neoplasms

  2018cites this paper
• Hypoxia-inducible KDM3A addiction in multiple myeloma.

  2018influential citation
• FoxM1 is regulated by both HIF-1α and HIF-2α and contributes to gastrointestinal stromal tumor progression

  2018cites this paper
• ARNT/HIF‐1β links high‐risk 1q21 gain and microenvironmental hypoxia to drug resistance and poor prognosis in multiple myeloma

  2018cites this paper
• Angiogenic Self-Assembling Peptide Scaffolds for Functional Tissue Regeneration.

  2018cites this paper
• Direct measurement of hypoxia in a xenograft multiple myeloma model by optical-resolution photoacoustic microscopy

  2017cites this paper
• Gambogenic Acid Exerts Antitumor Activity in Hypoxic Multiple Myeloma Cells by Regulation of miR-21

  2017cites this paper
• HIF-2α Promotes Dissemination of Plasma Cells in Multiple Myeloma by Regulating CXCL12/CXCR4 and CCR1.

  2017influential citation
• E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271

  2017cites this paper
• Hypoxia‐inducible microRNA‐210 regulates the DIMT1‐IRF4 oncogenic axis in multiple myeloma

  2017cites this paper
• Restoring Natural Killer Cell Immunity against Multiple Myeloma in the Era of New Drugs

  2017cites this paper
• Network-based analysis of the molecular mechanisms of multiple myeloma and monoclonal gammopathy of undetermined significance

  2017cites this paper
• Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss.

  2017influential citation
• Knockdown of myeloid cell hypoxia-inducible factor-1α ameliorates the acute pathology in DSS-induced colitis

  2017cites this paper
• EVALUATION OF p300 AND VEGF EXPRESSION AND MICROVESSEL DENSITY IN PLASMA CELL MYELOMA MYELOMDA p VE VEGF EKSPRESYONU İLE

  2017cites this paper
• Mitochondria and stem cell function: from somatic cells to iPSC-based disease modeling

  2017cites this paper
• Određivanje promjene u ekspresiji gena CAIX i katalitičke aktivnosti ugljične anhidraze u stanicama izloženim derivatima N-9 sulfonilurea

  2017cites this paper
• Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma

  2016cites this paper
• Exosomes promote bone marrow angiogenesis in hematologic neoplasia: the role of hypoxia

  2016cites this paper
• Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo

  2016cites this paper
• Hypoxia and Hypoxia-Inducible Factors in Leukemias

  2016cites this paper
• Targeted knockdown of DJ-1 induces multiple myeloma cell death via KLF6 upregulation

  2016cites this paper
• HIF-1α and rapamycin act as gerosuppressant in multiple myeloma cells upon genotoxic stress

  2016cites this paper
• Targeting unique oxidative metabolism of clonogenic multiple myeloma cells for therapy

  2016cites this paper
• A DNA-binding Molecule Targeting the Adaptive Hypoxic Response in Multiple Myeloma Has Potent Antitumor Activity

  2016cites this paper
• MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment

  2016cites this paper
• Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma

  2016cites this paper
• Effect of hypoxia-inducible factors in normal and leukemic stem cell regulation and their potential therapeutic impact

  2016cites this paper
• Potential therapeutic effects of natural extracts in multiple myeloma

  2016cites this paper
• Risk stratification in myeloma by detection of circulating plasma cells prior to autologous stem cell transplantation in the novel agent era

  2016cites this paper
• ISSN 2320-5407 International Journal of Advanced Research (2016), Volume 4, Issue 1, 706- 715

  2016cites this paper
• The anti-tumoral effect of lenalidomide is increased in vivo by hypoxia-inducible factor (HIF)-1α inhibition in myeloma cells

  2016cites this paper
• Nuclear medicine imaging of multiple myeloma, particularly in the relapsed setting

  2016cites this paper
• Hypoxia inducible factor-1 alpha and multiple myeloma.

  2016cites this paper
• Anergic bone marrow Vγ9Vδ2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma

  2015cites this paper
• Multiple myeloma as a model for the role of bone marrow niches in the control of angiogenesis.

  2015cites this paper
• Targeting the bone marrow microenvironment in multiple myeloma

  2015cites this paper
• Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A

  2015cites this paper
• 18F-FDG PET Increases Visibility of Bone Lesions in Relapsed Multiple Myeloma: Is This Hypoxia-Driven?

  2015cites this paper
• Down-regulating HIF-1α by lentivirus-mediated shRNA for therapy of triple negative breast cancer

  2015cites this paper
• DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myeloma.

  2015cites this paper
• HIF-1α decoy oligodeoxynucleotides inhibit HIF-1α signaling and breast cancer proliferation.

  2015cites this paper
• The role of prolyl hydroxylases in the function of leukaemic stem cells and the development of leukaemia

  2015cites this paper
• The Leukemic Bone Marrow Microenvironment: Targeting Hypoxia with Hypoxia-Activated Prodrugs

  2015cites this paper
• eIF4E and eIF4GI have distinct and differential imprints on multiple myeloma's proteome and signaling

  2015cites this paper
• Therapeutic targeting of hypoxia and hypoxia-inducible factor 1 alpha in multiple myeloma.

  2015cites this paper
• Metabolic Signature Identi fi es Novel Targets for Drug Resistance in Multiple Myeloma

  2015cites this paper
• Dynamic balance of multiple myeloma clonogenic side population cell percentages controlled by environmental conditions

  2015cites this paper
• Metabolic signature identifies novel targets for drug resistance in multiple myeloma.

  2015cites this paper
• Down Regulation of Wnt Signaling Mitigates Hypoxia-Induced Chemoresistance in Human Osteosarcoma Cells

  2014cites this paper
• Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity

  2014cites this paper
• A novel fluorometric assay for aldo-keto reductase 1C3 predicts metabolic activation of the nitrogen mustard prodrug PR-104A in human leukaemia cells.

  2014cites this paper
• Gambogic acid suppresses hypoxia-induced hypoxia-inducible factor-1α/vascular endothelial growth factor expression via inhibiting phosphatidylinositol 3-kinase/Akt/mammalian target protein of rapamycin pathway in multiple myeloma cells

  2014cites this paper
• Intermittent Hypoxia: Mechanistic Pathways Influencing Cancer

  2014cites this paper
• Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1.

  2014cites this paper
• The Role of the “Cancer Stem Cell Niche” in Cancer Initiation and Progression

  2014cites this paper
• Bone resorption facilitates osteoblastic bone metastatic colonization by cooperation of insulin-like growth factor and hypoxia

  2014cites this paper
• The bone marrow niche in the pathogenesis of multiple myeloma: A role for Wnt signaling and adrenomedullin

  2014cites this paper
• New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)

  2014cites this paper
• Bone marrow vascular niche and the control of angiogenesis in multiple myeloma.

  2014cites this paper